Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen Heitzer

Showing results (51-60 of 143) with videos related to

Pageof 15
Sort By:
Cancers|March 14, 2020
Functional Classification of <i>TP53</i> Mutations in Acute Myeloid LeukemiaSayantanee Dutta, Gudrun Pregartner, Frank G Rücker, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 19, 2012
Interviews with patients with advanced cancer--another step towards an international cancer pain classification systemAnne Kari Knudsen, Nina Aass, Ellen Heitzer, et al.
Palliative Medicine|November 24, 2012
Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment studyClare Rayment, Marianne J Hjermstad, Nina Aass, et al.
The Journal of Investigative Dermatology|March 25, 2006
T1799A BRAF mutation is common in PUVA lentiginesAnita Lassacher, Miriam Worda, Steven Kaddu, et al.
BMC Cancer|July 26, 2013
Genetic and epigenetic analysis of putative breast cancer stem cell modelsMarija Balic, Daniela Schwarzenbacher, Stefanie Stanzer, et al.
Pain Physician|November 20, 2012
IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancerEllen Heitzer, Andreas Sandner-Kiesling, Walter Schippinger, et al.
Pediatric Blood & Cancer|April 4, 2017
A novel mutation in ATRX associated with intellectual disability, syndromic features, and osteosarcomaMaria A Smolle, Ellen Heitzer, Jochen B Geigl, et al.
Molecular Oncology|December 2, 2020
Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR<sup>+</sup> breast cancer patients undergoing CDK4/6 treatmentNadia Dandachi, Florian Posch, Ricarda Graf, et al.
Haematologica|October 13, 2018
Clinical implications of subclonal <i>TP53</i> mutations in acute myeloid leukemiaKatharina T Prochazka, Gudrun Pregartner, Frank G Rücker, et al.
Scientific Reports|April 14, 2016
Establishment of clival chordoma cell line MUG-CC1 and lymphoblastoid cells as a model for potential new treatment strategiesVerena Gellner, Peter Valentin Tomazic, Birgit Lohberger, et al.
Pageof 15

Showing results (51-60 of 143) with videos related to

Sort By:
Pageof 15
Cancers|March 14, 2020
Functional Classification of <i>TP53</i> Mutations in Acute Myeloid LeukemiaSayantanee Dutta, Gudrun Pregartner, Frank G Rücker, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 19, 2012
Interviews with patients with advanced cancer--another step towards an international cancer pain classification systemAnne Kari Knudsen, Nina Aass, Ellen Heitzer, et al.
Palliative Medicine|November 24, 2012
Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment studyClare Rayment, Marianne J Hjermstad, Nina Aass, et al.
The Journal of Investigative Dermatology|March 25, 2006
T1799A BRAF mutation is common in PUVA lentiginesAnita Lassacher, Miriam Worda, Steven Kaddu, et al.
BMC Cancer|July 26, 2013
Genetic and epigenetic analysis of putative breast cancer stem cell modelsMarija Balic, Daniela Schwarzenbacher, Stefanie Stanzer, et al.
Pain Physician|November 20, 2012
IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancerEllen Heitzer, Andreas Sandner-Kiesling, Walter Schippinger, et al.
Pediatric Blood & Cancer|April 4, 2017
A novel mutation in ATRX associated with intellectual disability, syndromic features, and osteosarcomaMaria A Smolle, Ellen Heitzer, Jochen B Geigl, et al.
Molecular Oncology|December 2, 2020
Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR<sup>+</sup> breast cancer patients undergoing CDK4/6 treatmentNadia Dandachi, Florian Posch, Ricarda Graf, et al.
Haematologica|October 13, 2018
Clinical implications of subclonal <i>TP53</i> mutations in acute myeloid leukemiaKatharina T Prochazka, Gudrun Pregartner, Frank G Rücker, et al.
Scientific Reports|April 14, 2016
Establishment of clival chordoma cell line MUG-CC1 and lymphoblastoid cells as a model for potential new treatment strategiesVerena Gellner, Peter Valentin Tomazic, Birgit Lohberger, et al.
Pageof 15